Associations in tumor infiltrating lymphocytes between clinicopathological factors and clinical outcomes in estrogen receptor-positive/human epidermal growth factor receptor type 2 negative breast cancer

The value of assessing tumor infiltrating lymphocytes (TILs) in estrogen receptor (ER) positive/human epidermal growth factor receptor type 2 (HER2) negative breast cancer has yet to be determined. In the present study, a total of 184 cases with early distant recurrence detected within 5 years follo...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyoshi, Yuichiro, Shien, Tadahiko, Ogiya, Akiko, Ishida, Naoko, Yamazaki, Kieko, Horii, Rie, Horimoto, Yoshiya, Masuda, Norikazu, Yasojima, Hiroyuki, Inao, Touko, Osako, Tomofumi, Takahashi, Masato, Tomioka, Nobumoto, Wanifuchi-Endo, Yumi, Hosoda, Mitsuchika, Doihara, Hiroyoshi, Yamashita, Hiroko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341802/
https://www.ncbi.nlm.nih.gov/pubmed/30675282
http://dx.doi.org/10.3892/ol.2018.9853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341802/
https://www.ncbi.nlm.nih.gov/pubmed/30675282
http://dx.doi.org/10.3892/ol.2018.9853

Ejemplares similares